Detected ·
Moonwalk Biosciences
$70M—
Moonwalk Biosciences closed an oversubscribed $70M Series B to advance its adipose-targeted RNAi medicines for obesity and cardiometabolic diseases, co-led by Alpha Wave and YK Bioventures with participation from Eli Lilly, Gaorong Ventures, ARCH Venture Partners, Khosla Ventures and Future Ventures.
- Website
- moonwalk.bio
- Amount
- $70 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-09-09 04:25:48 UTC
- Signal ID
- bd2c0751-9f25-4553-9a52-9b03f80c4b79
As the API returns it
{
"id": "bd2c0751-9f25-4553-9a52-9b03f80c4b79",
"created_at": "2026-09-09T04:25:48.091968Z",
"company_name": "Moonwalk Biosciences",
"company_website_url": "moonwalk.bio",
"company_linkedin_url": "https://www.linkedin.com/company/moonwalk-biosciences",
"event_type": "funding",
"funding_amount": 70000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Moonwalk Biosciences closed an oversubscribed $70M Series B to advance its adipose-targeted RNAi medicines for obesity and cardiometabolic diseases, co-led by Alpha Wave and YK Bioventures with participation from Eli Lilly, Gaorong Ventures, ARCH Venture Partners, Khosla Ventures and Future Ventures.*"
}